CLIA lab
CLIA 45D2095888: Crossroads Nursing & Rehabilitation
Hearne, TX. Certificate and address details from the CMS Provider of Services file for clinical laboratories.
CLIA number 45D2095888 belongs to Crossroads Nursing & Rehabilitation in Hearne, TX.
Certificate of Waiver, effective May 13, 2025, expires May 12, 2027.
Active in the CMS Provider of Services file posted October 16, 2026.
Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page
Run it in Rivvi
Map your lab's test names to LOINC codes
Open in RivviFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Certificate
- Certificate type
- Certificate of Waiver
- Certificate effective
- May 13, 2025
- Certificate expiration
- May 12, 2027
- Status in the CMS file
- Active (termination code 00)
- Original participation date
- May 13, 2015
- Facility type
- Skilled nursing or nursing facility
- Ownership (control type)
- Proprietary
- Lab classification
- CLIA laboratory
Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page
Lab and contact
- CLIA number
- 45D2095888
- Lab name
- Crossroads Nursing & Rehabilitation
- Address
- 611 Rose Marie Blvd, Hearne, TX 77859
- Phone
- (979) 280-0440
- Fax
- (979) 280-0448
Annual test volume the lab reported
- Waived tests
- 14,000
Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.
Care facility at this address
- Crossroads Nursing & RehabilitationCMS Care Compare ratings for the facility at the same street address
Other labs in Hearne, TX
Related
Questions
What is the CLIA number for Crossroads Nursing & Rehabilitation in Hearne?
45D2095888, per the CMS Provider of Services file posted October 16, 2026.
What CLIA certificate does Crossroads Nursing & Rehabilitation hold?
A Certificate of Waiver, according to the CMS file.
When does CLIA 45D2095888 expire?
The CMS file lists May 12, 2027 as the certificate expiration date; the certificate took effect May 13, 2025.